Showing results 1 to 6 of 6
| Title | Author(s) | Issue Date | |
|---|---|---|---|
Decoding CLU (Clusterin): Conquering cancer treatment resistance and immunological barriers Journal:International Immunopharmacology | 20-Aug-2024 | ||
Degraders in epigenetic therapy: PROTACs and beyond Journal:Theranostics | 27-Jan-2024 | ||
Editorial: Epigenetic mechanisms and post-translational modifications as novel therapeutic targets in cancer Journal:Frontiers in Pharmacology | 8-Aug-2022 | ||
Neddylation-dependent LSD1 destabilization inhibits the stemness and chemoresistance of gastric cancer Journal:International Journal of Biological Macromolecules | 7-Sep-2023 | ||
Novel acridine-based LSD1 inhibitors enhance immune response in gastric cancer Journal:European Journal of Medicinal Chemistry | 29-Jul-2023 | ||
USP7 as an emerging therapeutic target: A key regulator of protein homeostasis Journal:International Journal of Biological Macromolecules | 1-Apr-2024 |
